Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Compassionate Access of the Miltenyi Device for CD34+ Cell Selection

NCT: NCT02438904 · RECRUITING

NCT IDNCT02438904
StatusRECRUITING
Start Date2015-05-06
Completion2027-05-01

Brief Summary

Objectives: Primary Objective To provide compassionate access to the Miltenyi device for CD34+ cell infusions to patients who experience poor graft function after stem cell transplantation (SCT).

Frequently Asked Questions

What is Compassionate Access of the Miltenyi Device for CD34+ Cell Selection?

Compassionate Access of the Miltenyi Device for CD34+ Cell Selection is a clinical trial registered under NCT02438904. Current status: RECRUITING.

What is the status of NCT02438904?

The current status of NCT02438904 (Compassionate Access of the Miltenyi Device for CD34+ Cell Selection) is: RECRUITING.

When did Compassionate Access of the Miltenyi Device for CD34+ Cell Selection start?

Compassionate Access of the Miltenyi Device for CD34+ Cell Selection started on 2015-05-06.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑